VCP and cancer: This broad involvement of VCP in intracellular protein turnover, combined with observations of aberrant VCP expression in different cancers,32, 33, 34, 35, 36, 37, 38, 39, 40 suggests that VCP inhibitors may overcome some limitations of proteasome inhibitors by affecting multiple proteostatic mechanisms simultaneously.